Prosecution Insights
Prosecution Insights
3 pending office actions • 2 art units • 3 examiners • 2 of 3 (67%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THOMAS, COURTNEY D | 1 | 89.1% | +9.2% |
| BEHARRY, ZANNA MARIA | 1 | 23.2% | +52.7% |
| WANG, CHANG YU | 1 | 33.4% | +53.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18878312 | METHOD OF MONITORING PARAMETERS IN TURBID SOLUTIONS | THOMAS, COURTNEY D | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042179 | CD91 POLYPEPTIDE FOR USE IN DETECTING HEMOPEXIN:HEME COMPLEX | BEHARRY, ZANNA MARIA | 60d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16606605 | IMMUNOGLOBULIN PRODUCTS FOR USE IN THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY | WANG, CHANG YU | 125d overdue |
| 18042179 | CD91 POLYPEPTIDE FOR USE IN DETECTING HEMOPEXIN:HEME COMPLEX | BEHARRY, ZANNA MARIA | 60d overdue |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18878312 | METHOD OF MONITORING PARAMETERS IN TURBID SOLUTIONS | THOMAS, COURTNEY D | — | §103 | Non-Final OA | — | Pending | Dec 23, 2024 |
| 18042179 | CD91 POLYPEPTIDE FOR USE IN DETECTING HEMOPEXIN:HEME COMPLEX | BEHARRY, ZANNA MARIA | 1632 | §102§103§112 | Non-Final OA | 60d overdue | AI Ready | Feb 17, 2023 |
| 16606605 | IMMUNOGLOBULIN PRODUCTS FOR USE IN THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY | WANG, CHANG YU | 1675 | §103 | Final Rejection | 125d overdue | AI Ready | Oct 18, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial